Timothy P. Endy, MD, MPH, FACP, COL (Ret), USA
Dr. Endy is currently the Chief, Infectious Disease Division, Associate Professor, Department of Medicine; Adjunct Associate Professor in the Department of Microbiology and Immunology, School of Graduate Studies; and Adjunct Associate Professor, Department of Preventive Medicine at the SUNY Upstate Medical University. He is a Board Certified physician in the subspecialty of Infectious Diseases and Internal Medicine and did his residency and fellowship training at the Walter Reed Army Medical Center, Washington, DC. Dr. Endy obtained his medical school training at the Uniformed Services University, F. Edward Herbert School of Medicine, Bethesda, MD; received an MPH in Epidemiology from the University of Michigan, School of Public Health, Ann Arbor, MI; and a BS degree from the Pennsylvania State University, University Park, PA. He served with distinction in the United States Army for 24 years and retired as a Colonel in 2006.
Dr. Endy has a broad area of expertise in the field of Clinical and Translational Research. He has conducted basic science research in the field of virology, developed vaccine field and epidemiological study sites in Southeast and Central Asia, conducted phase I and II clinical vaccine trials and active in the development and management of research programs that are product oriented towards developing vaccines and diagnostics that meet FDA regulatory requirements. He was the past Program Coordinator for the development of an active epidemiologic and diagnostic surveillance program in Central Asia for the select agent pathogens funded by the Biological Weapons Proliferation Protection Program, Defense Threat Reduction Agency and has served on two panels at the National Academy of Science on Threat Reduction of Biological Weapons.
Dr. Endy is considered an international expert in the field of dengue and dengue hemorrhagic fever and emerging viral pathogens. Dr. Endy is an active reviewer for five peer reviewed journals, a subject matter expert on dengue and dengue vaccine development for the Bill and Melinda Gates Foundation, and a NIH funded researcher conducting studies on dengue in Thailand. He has published over 70 manuscripts in peer reviewed journals, published 8 book chapters and has presented to numerous international conferences and symposiums.